To cite this paper use one of the standards below:
The components of coffee can alter glycemic responses through mechanisms such as the inhibition of glycolytic enzymes, so they can be considered as potential hypoglycemic substances in diabetes therapy. Therefore, the aim of this study was to evaluate the ability of coffee drinks without and with added ingredients to inhibit the alpha-glucosidase enzyme at different concentrations. Caffeinated and decaffeinated coffee powders were purchased from stores in the city of São Paulo, Brazil. The drinks were prepared according to the manufacturer's standards, and versions were produced with added ingredients (milk, sugar, milk with sugar). The coffee drinks were digested in vitro and used in an alpha-glucosidase enzyme inhibition analysis. The samples were tested in 5 different dilutions. Samples of pure caffeinated coffee and pure decaffeinated coffee showed enzyme inhibition power between 96.4% and 100%, with a concentration range between 3.46 mg/mL TSS (total soluble solids) and 17.3 mg/mL TSS, and 2.9 mg/mL TSS and 14.5 mg/mL TSS, respectively. The inhibitory capacity of caffeinated coffee with sugar ranged from 88.4% to 97.5%, at concentrations between 10.3 mg/mL TSS and 103.6 mg/mL TSS, while the inhibitory action of decaffeinated coffee with sugar showed an inhibitory power of 97.1% to 99.6%, observed at concentrations between 17.9 mg/mL TSS and 89.8 mg/mL TSS. The decaffeinated coffees with milk and with milk and sugar showed inhibitory capacity even at lower concentrations, such as 3.1 mg/mL TSS and 7.6 mg/mL TSS, as did the caffeinated coffee with added milk, which showed inhibitory power of 96.8% at a concentration of 5.8 mg/mL TSS. These results show the promising inhibitory potential of coffee drinks, especially decaffeinated coffee with milk, suggesting possible positive interactions between the inhibitory capacity of milk and coffee components, even in the absence of caffeine.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper